Project Grant R21AT013757
- The National Center for Complementary and Integrative Health of the Department of Health and Human Services awarded Southern California University of Health Sciences $535,524 on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to assess the quality and value of non-pharmacological therapies compared to prescription drug therapy for managing spinal pain in Medicare beneficiaries aged 65 and older. The research will use Medicare...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded Duke University $444,125 on August 13, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to test the feasibility and acceptability of a psychological support and resource navigator program for orthopedic patients with high-impact chronic musculoskeletal pain. The navigator program addresses the...
- The National Center for Complementary and Integrative Health, under the Department of Health and Human Services National Institutes of Health, awarded The Trustees of Columbia University in the City of New York $167,400 on April 10, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The project characterizes neural circuits regulating the adrenal medulla during stress responses. Specifically, the work maps connections between the motor cortex and...
- The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health awarded The General Hospital Corporation, doing business as Massachusetts General Hospital, $170,640 on April 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development and feasibility testing of TOPMED (Toolkit for Optimal Pain Management in the Emergency Department), a mind-body intervention designed to reduce pain...
- The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded $439,500 to the University of California, San Diego on April 1, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development of structural biology tools to enable high-resolution cryo-EM elucidation of type I polyketide synthases isolated directly from natural producer...
- The National Center for Complementary and Integrative Health (NCCIH), a component of the Department of Health and Human Services National Institutes of Health, awarded $407,856 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University on August 1, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The recipient will conduct research examining how alpha-frequency transcranial alternating current stimulation (tACS) targeting...
- The National Center for Complementary and Integrative Health awarded Carnegie Mellon University $616,764 on September 1, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to develop and investigate a bidirectional brain-computer interface (BI-BCI) platform combining electroencephalography-based neural decoding with closed-loop transcranial focused ultrasound neuromodulation. The award funds two specific research aims. Aim 1 establishes a...
- The National Center for Complementary and Integrative Health (NCCIH) awarded the University of Massachusetts Medical School a $297,373 cooperative agreement on August 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a Data Coordinating Center (U24) to provide statistical and data management leadership for a multi-center Phase 3 randomized controlled trial (ACUITY 2) examining whether acupuncture is superior to usual care for...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Carnegie Mellon University $1.04 million on April 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and validate a sensorized compression sleeve for muscle-activity monitoring and rehabilitation tracking in patients following anterior cruciate ligament reconstruction. The research investigates capacitive sensing embedded in e-textiles as a tool to...
- Federal Grant Award Summary Western University of Health Sciences received a $390,979 Project Grant from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), effective September 1, 2025 through August 31, 2027. The award funds an exploratory research initiative investigating the dynamics and heteromerization of PIEZO channel subunits—mechanosensitive ion channels responsible for...
The National Center for Complementary and Integrative Health, part of the Department of Health and Human Services National Institutes of Health, awarded $398,970 to the University of Alabama at Birmingham on August 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development of soft wearable electronic skin sensors to quantify real-time complex force dynamics during force-based manipulation and manual therapy. The soft e-skin technology, produced through digital manufacturing, enables clinicians to measure mechanical forces and pressures at high spatiotemporal resolution without tactile interference during spinal mobilization, spinal manipulation, massage, and other force-based manual treatments. The sensors feature a broad dynamic range exceeding 560 kilopascals, millisecond-level response time, high sensitivity including detection at single-hair weight thresholds, and low hysteresis. This instrumentation addresses standardization and mechanism-related knowledge gaps that have limited therapeutic optimization and clinical trial comparability in force-based manipulation, which is currently recommended as a first-line conservative treatment for musculoskeletal pain including low back pain. Work is performed in Birmingham, Alabama. The period of performance extends from August 15, 2026, through July 31, 2028. This is a Project Grant, the standard NIH research grant assistance type for investigator-initiated research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $399.0k | 8/18/26 |